Viridian Therapeutics, Inc.\DE (VRDN) Revenue (2013 - 2026)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Revenue came in at $141000.0 in Q1 2026, up 95.83% year-on-year from $72000.0 in Q1 2025, and up 6.82% quarter-over-quarter from $132000.0 in Q4 2025.
Viridian Therapeutics, Inc.\DE (VRDN) Revenue (2013 - 2026) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Revenue history runs 14 years deep, the most recent figure standing at $141000.0 for Q1 2026.
- On a quarterly basis, Revenue rose 95.83% year-over-year to $141000.0 in Q1 2026; TTM through Mar 2026 was $70.9 million, a 23382.78% increase from a year earlier, with the FY2025 full-year figure at $70.8 million, up 23359.93% from the prior year.
- Revenue advanced to $141000.0 in Q1 2026 per VRDN's latest filing, from $132000.0 in the prior quarter.
- Across five years, Revenue topped out at $70.6 million in Q3 2025 and bottomed at $72000.0 in Q2 2023.
- The 5-year median for Revenue is $86000.0 (2024), against an average of $4.3 million.
- Across the five-year window, Revenue slumped 93.97% in 2023 and surged 81958.14% in 2025, its largest moves.
- Year by year, Revenue stood at $105000.0 in 2022, then tumbled by 31.43% to $72000.0 in 2023, then changed by 0.0% to $72000.0 in 2024, then soared by 83.33% to $132000.0 in 2025, then increased by 6.82% to $141000.0 in 2026.
- Per Business Quant, the three latest VRDN Revenue figures stand at $141000.0 (Q1 2026), $132000.0 (Q4 2025), and $70.6 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 229.55 Mn | 229.55 Mn | - | 141,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 141,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 70.57 Mn |
| Jun 30, 2025 | 75,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Sep 30, 2024 | 86,000.00 |
| Jun 30, 2024 | 72,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Dec 31, 2023 | 72,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 72,000.00 |
| Mar 31, 2023 | 98,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 256,000.00 |
| Mar 31, 2022 | 216,000.00 |
| Dec 31, 2021 | 214,000.00 |
| Sep 30, 2021 | 208,000.00 |
| Jun 30, 2021 | 1.09 Mn |